Cover Image

Imaging of prostate cancer

Background: Prostate cancer is the most common type of solid tumor in men and the second most common cause of cancer-related death in males in Germany. The conventional strategy for its primary detection, i.e., systematic ultrasound-guided prostate biopsy in men who have elevated PSA levels and/or p...

Full description

Saved in:
Bibliographic Details
Main Authors: Schlemmer, Heinz-Peter (Author) , Krause, Bernd Joachim (Author) , Schütz, Viktoria (Author) , Bonekamp, David (Author) , Schwarzenboeck, Sarah Marie (Author) , Hohenfellner, Markus (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Deutsches Ärzteblatt
Year: 2021, Volume: 118, Issue: 42, Pages: 713-719
ISSN:1866-0452
DOI:10.3238/arztebl.m2021.0309
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3238/arztebl.m2021.0309
Verlag, lizenzpflichtig, Volltext: https://www.aerzteblatt.de/int/archive/article/221646
Get full text
Author Notes:Heinz-Peter Schlemmer, Bernd Joachim Krause, Viktoria Schuetz, David Bonekamp, Sarah Marie Schwarzenboeck, Markus Hohenfellner

MARC

LEADER 00000caa a2200000 c 4500
001 1816701610
003 DE-627
005 20230118162239.0
007 cr uuu---uuuuu
008 220915s2021 xx |||||o 00| ||eng c
024 7 |a 10.3238/arztebl.m2021.0309  |2 doi 
035 |a (DE-627)1816701610 
035 |a (DE-599)KXP1816701610 
035 |a (OCoLC)1361714368 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schlemmer, Heinz-Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1025559967  |0 (DE-627)722927142  |0 (DE-576)17334805X  |4 aut 
245 1 0 |a Imaging of prostate cancer  |c Heinz-Peter Schlemmer, Bernd Joachim Krause, Viktoria Schuetz, David Bonekamp, Sarah Marie Schwarzenboeck, Markus Hohenfellner 
264 1 |c 2021 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.09.2022 
520 |a Background: Prostate cancer is the most common type of solid tumor in men and the second most common cause of cancer-related death in males in Germany. The conventional strategy for its primary detection, i.e., systematic ultrasound-guided prostate biopsy in men who have elevated PSA levels and/or positive findings on digital rectal examination, fails to reveal all cases. The same is true of the use of conventional computed tomography (CT), magnetic resonance imaging (MRI), and skeletal scintigraphy for the early detection of recurrences and distant metastases. Methods: This review is based on pertinent publications retrieved by a selective search, including the German clinical practice guideline on prostate cancer and systematic review articles. Results: Prospective multicenter trials have shown that the detection of clinically significant prostate cancer is markedly improved with multiparametric MRI (mpMRI) and MR/TRUS fusion biopsy (TRUS = transrectal ultrasonography), compared to conventional systematic biopsy. A recent Cochrane review showed that the rate of overdiagnosis of low-risk prostate cancer was reduced with mpMRI and MR/TRUS fusion biopsy compared with conventional systematic biopsy (95/1000 vs. 139/1000), and that clinically significant prostate cancer was more reliably detected (sensitivity 72% vs. 63%), albeit with slightly lower specificity (96% vs. 100%). Prostate-specific membrane antigen (PSMA) hybrid imaging improves the detection of lymphogenic and bony metastases in patients with high-risk prostate cancer. PSMA hybrid imaging is most commonly used to detect biochemical recurrences. A meta analysis showed that the detection rate depends on the PSA concentration: 74.1% overall, 33.7% with PSA <0.2 ng/mL, and 91.7% with PSA >== 2.0 ng/mL. Conclusion: The appropriate use of mpMRI and MR/TRUS fusion biopsy improves the initial detection of prostate cancer as well as the assessment of the prognosis. PSMA hybrid imaging is useful for the staging of high-risk patients and for the detection of recurrences. These methods are now recommended in the German clinical practice guideline on prostate cancer as well as in guidelines from other countries. 
650 4 |a antigen 
650 4 |a men 
650 4 |a mri 
650 4 |a radical prostatectomy 
650 4 |a risk 
650 4 |a targeted biopsy 
650 4 |a therapy 
700 1 |a Krause, Bernd Joachim  |e VerfasserIn  |4 aut 
700 1 |a Schütz, Viktoria  |e VerfasserIn  |0 (DE-588)1183860021  |0 (DE-627)1663385335  |4 aut 
700 1 |a Bonekamp, David  |d 1977-  |e VerfasserIn  |0 (DE-588)128868104  |0 (DE-627)383668581  |0 (DE-576)297371797  |4 aut 
700 1 |a Schwarzenboeck, Sarah Marie  |e VerfasserIn  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
773 0 8 |i Enthalten in  |t Deutsches Ärzteblatt  |b International : a weekly online journal of clinical medicine and public health  |d Köln : Dt. Ärzte-Verl., 2006  |g 118(2021), 42, Seite 713-719  |h Online-Ressource  |w (DE-627)557878810  |w (DE-600)2406159-1  |w (DE-576)281368007  |x 1866-0452  |7 nnas  |a Imaging of prostate cancer 
773 1 8 |g volume:118  |g year:2021  |g number:42  |g pages:713-719  |g extent:7  |a Imaging of prostate cancer 
856 4 0 |u https://doi.org/10.3238/arztebl.m2021.0309  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.aerzteblatt.de/int/archive/article/221646  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220915 
993 |a Article 
994 |a 2021 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 6  |y j 
998 |g 128868104  |a Bonekamp, David  |m 128868104:Bonekamp, David  |d 50000  |e 50000PB128868104  |k 0/50000/  |p 4 
998 |g 1183860021  |a Schütz, Viktoria  |m 1183860021:Schütz, Viktoria  |d 910000  |d 910200  |e 910000PS1183860021  |e 910200PS1183860021  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1025559967  |a Schlemmer, Heinz-Peter  |m 1025559967:Schlemmer, Heinz-Peter  |d 50000  |e 50000PS1025559967  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1816701610  |e 418879545X 
BIB |a Y 
SER |a newspaper 
JSO |a {"language":["eng"],"type":{"bibl":"article-newspaper","media":"Online-Ressource"},"person":[{"given":"Heinz-Peter","family":"Schlemmer","role":"aut","display":"Schlemmer, Heinz-Peter"},{"display":"Krause, Bernd Joachim","role":"aut","given":"Bernd Joachim","family":"Krause"},{"given":"Viktoria","family":"Schütz","role":"aut","display":"Schütz, Viktoria"},{"family":"Bonekamp","given":"David","role":"aut","display":"Bonekamp, David"},{"family":"Schwarzenboeck","given":"Sarah Marie","role":"aut","display":"Schwarzenboeck, Sarah Marie"},{"display":"Hohenfellner, Markus","role":"aut","given":"Markus","family":"Hohenfellner"}],"id":{"doi":["10.3238/arztebl.m2021.0309"],"eki":["1816701610"]},"note":["Gesehen am 15.09.2022"],"physDesc":[{"extent":"7 S."}],"relHost":[{"pubHistory":["103.2006 -"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Deutsches Ärzteblatt","title":"Deutsches Ärzteblatt"}],"language":["eng","ger"],"type":{"media":"Online-Ressource","bibl":"newspaper"},"disp":"Imaging of prostate cancerDeutsches Ärzteblatt","id":{"eki":["557878810"],"issn":["1866-0452"],"zdb":["2406159-1"]},"origin":[{"publisherPlace":"Köln","edition":"International : a weekly online journal of clinical medicine and public health","dateIssuedKey":"2006","dateIssuedDisp":"2006-","publisher":"Dt. Ärzte-Verl."}],"recId":"557878810","part":{"issue":"42","year":"2021","text":"118(2021), 42, Seite 713-719","extent":"7","volume":"118","pages":"713-719"},"note":["Gesehen am 15.8.2025"],"titleAlt":[{"title":"Deutsches Ärzte-Blatt"}]}],"name":{"displayForm":["Heinz-Peter Schlemmer, Bernd Joachim Krause, Viktoria Schuetz, David Bonekamp, Sarah Marie Schwarzenboeck, Markus Hohenfellner"]},"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"Imaging of prostate cancer","title":"Imaging of prostate cancer"}],"recId":"1816701610"} 
SRT |a SCHLEMMERHIMAGINGOFP2021 

Similar Items